Enduring response to everolimus as third-line therapy in a patient with advanced renal cell carcinoma, including small-bowel metastases: loss of FHIT but normal VHL gene status.
作者信息
Broom Reuben J, Caldwell Imogen, Hanning Fritha, Fong Peter, Deva Sanjeev, Oei Paul
机构信息
Department of Medical Oncology, Regional Cancer and Blood Service, Auckland City Hospital, Auckland, New Zealand.
出版信息
Clin Genitourin Cancer. 2012 Sep;10(3):202-6. doi: 10.1016/j.clgc.2012.01.008. Epub 2012 Mar 21.
PMID:22440786
Abstract
摘要
Zotero 插件